Research Report on Rat Model Market Globally strategic overview july 2019

Rat Model Market by Model Type (Outbred, Inbred, Knockout),
Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology,
Oncology), Service (Breeding, Cryopreservation), Care Products
(Cages, Feed, Bedding) & End User -Global Forecast to 2021
According to the new market research report "Rat Model Market by Model Type (Outbred,
Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology,
Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End
User -Global Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the
major market drivers, restraints/challenges, and opportunities.
The Global Rat Model Market is expected to reach $588.9 Million, growing at a CAGR of 8.7%
The global rat model market is segmented on the basis of model type, service, therapeutic area,
technology, end user, care product, and region.
Read More in Detailed: https://www.marketsandmarkets.com/PressReleases/rat-model.asp
On the basis of model type, the market is categorized into outbred rat, inbred rats,
knockout/genetically modified rats, conditioned/surgically modified rats, hybrid/congenic rats,
and immunodeficient rats. In 2016, the outbred rats segment is estimated to account for the
largest share of the global rat model market. However, the knockout/genetically modified rats
segment is expected to be the fastest-growing segment owing to the use of this type of rat
models to carry out researches on disease such as oncology, obesity, heart disease, diabetes,
arthritis, drug abuse, anxiety, aging, and Parkinson’s disease.
Browse and in-depth TOC on "Rat Model Market"
132 - Tables
47 - Figures
253 - Pages
On the basis of technology, the market is segmented into CRISPR, microinjection, embryonic
stem cell injection, nuclear transfer, and other technologies (genetically modified sperm-
mediated gene transfer, virus/vector mediated gene transfer, liposome-mediated DNA &
electroporation of DNA, biolistics, and TALENs & ZFN). In 2016, the CRISPR segment is expected
to command the largest share of the global rat model market.
1